Cargando…
Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy
EphA4 is a receptor of the Eph-ephrin system, which plays an important role in axon guidance during development. Previously, we identified EphA4 as a genetic modifier of amyotrophic lateral sclerosis (ALS) in both zebrafish and rodent models, via modulation of the intrinsic vulnerability, and re-spr...
Autores principales: | Poppe, Lindsay, Smolders, Silke, Rué, Laura, Timmers, Mieke, Lenaerts, Annette, Storm, Annet, Schoonaert, Lies, de Boer, Antina, Van Damme, Philip, Van Den Bosch, Ludo, Robberecht, Wim, Lemmens, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877733/ https://www.ncbi.nlm.nih.gov/pubmed/31803009 http://dx.doi.org/10.3389/fnins.2019.01233 |
Ejemplares similares
-
Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis
por: Rué, Laura, et al.
Publicado: (2019) -
EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer’s disease
por: Poppe, Lindsay, et al.
Publicado: (2019) -
Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017) -
Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy
por: de Boer, Antina, et al.
Publicado: (2020) -
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
por: Rué, Laura, et al.
Publicado: (2019)